Analyn Lizaso

1.3k total citations
36 papers, 851 citations indexed

About

Analyn Lizaso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Analyn Lizaso has authored 36 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Analyn Lizaso's work include Lung Cancer Treatments and Mutations (20 papers), Cancer Genomics and Diagnostics (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). Analyn Lizaso is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Cancer Genomics and Diagnostics (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). Analyn Lizaso collaborates with scholars based in China, United States and Taiwan. Analyn Lizaso's co-authors include Ying‐Hue Lee, Kien Thiam Tan, Han Han‐Zhang, Yongchang Zhang, Junyi Ye, Nong Yang, Xinru Mao, Rui Han, Yong He and Mengxiao Zhu and has published in prestigious journals such as European Journal of Cancer, Autophagy and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Analyn Lizaso

36 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Analyn Lizaso China 18 457 418 288 238 171 36 851
Elisabetta Zulato Italy 16 266 0.6× 342 0.8× 600 2.1× 492 2.1× 93 0.5× 37 1.0k
Addie Dvir Israel 13 375 0.8× 332 0.8× 304 1.1× 309 1.3× 90 0.5× 25 800
Spencer R. Rosario United States 12 615 1.3× 402 1.0× 701 2.4× 419 1.8× 32 0.2× 51 1.2k
Russell Broaddus United States 13 171 0.4× 489 1.2× 610 2.1× 272 1.1× 97 0.6× 15 1.1k
Clay E.S. Comstock United States 18 451 1.0× 363 0.9× 735 2.6× 290 1.2× 87 0.5× 22 1.2k
Sarab Lizard‐Nacol France 18 261 0.6× 393 0.9× 627 2.2× 331 1.4× 160 0.9× 33 1.1k
Takamitsu Onitsuka Japan 14 616 1.3× 635 1.5× 538 1.9× 212 0.9× 107 0.6× 28 1.2k
Helen Musgrove United Kingdom 6 289 0.6× 415 1.0× 441 1.5× 158 0.7× 71 0.4× 7 852
A-P Meert Belgium 7 799 1.7× 732 1.8× 548 1.9× 266 1.1× 68 0.4× 17 1.3k
Tomohiro Sakuma Japan 17 213 0.5× 282 0.7× 356 1.2× 253 1.1× 65 0.4× 23 796

Countries citing papers authored by Analyn Lizaso

Since Specialization
Citations

This map shows the geographic impact of Analyn Lizaso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Analyn Lizaso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Analyn Lizaso more than expected).

Fields of papers citing papers by Analyn Lizaso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Analyn Lizaso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Analyn Lizaso. The network helps show where Analyn Lizaso may publish in the future.

Co-authorship network of co-authors of Analyn Lizaso

This figure shows the co-authorship network connecting the top 25 collaborators of Analyn Lizaso. A scholar is included among the top collaborators of Analyn Lizaso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Analyn Lizaso. Analyn Lizaso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Ting, Xia Chen, Gong Chen, et al.. (2020). Efficacy of Joungal in preventing febrile neutropenia induced by platinum-based doublet chemotherapy in lung cancer. Annals of Palliative Medicine. 9(4). 1688–1695. 2 indexed citations
3.
Zhang, Yongchang, Liang Zeng, Chunhua Zhou, et al.. (2020). Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 15(6). 1027–1036. 42 indexed citations
4.
Cai, Zhenghao, Zhenxin Wang, Cheng‐Lin Liu, et al.. (2020). Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing. Journal of Molecular Diagnostics. 22(7). 860–870. 37 indexed citations
5.
Wang, Yubo, Panwen Tian, Lei Xia, et al.. (2020). The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy. Lung Cancer. 146. 165–173. 32 indexed citations
6.
Tang, Yuan, Yuli Li, Weiya Wang, et al.. (2020). Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method. Translational Lung Cancer Research. 9(1). 71–81. 13 indexed citations
7.
8.
9.
Tian, Panwen, Yujie Liu, Hao Zeng, et al.. (2020). Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes. Journal of Cancer Research and Clinical Oncology. 146(4). 935–944. 20 indexed citations
10.
11.
Xie, Zhanhong, Yingying Gu, Xiaohong Xie, et al.. (2020). Lung Adenocarcinoma Harboring Concomitant EGFR Mutations and BRAF V600E Responds to a Combination of Osimertinib and Vemurafenib to Overcome Osimertinib Resistance. Clinical Lung Cancer. 22(3). e390–e394. 21 indexed citations
12.
Zhou, Li, Xia Wang, Analyn Lizaso, et al.. (2019). <p>Efficacy of afatinib in a <em>HER2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p>. OncoTargets and Therapy. Volume 12. 5305–5309. 3 indexed citations
13.
Lin, Quan, Haoran Zhang, Jun Qian, et al.. (2019). The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients. Journal of Translational Medicine. 17(1). 298–298. 35 indexed citations
14.
Yang, Dongyong, Yalun Li, Li Li, et al.. (2019). Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients. Cancer Biology and Medicine. 16(3). 556–564. 35 indexed citations
15.
Xie, Zhanhong, Laiyu Liu, Xinqing Lin, et al.. (2019). A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung. Modern Pathology. 33(4). 626–638. 47 indexed citations
16.
Rao, Chuangzhou, et al.. (2019). Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report. Diagnostic Pathology. 14(1). 101–101. 2 indexed citations
17.
Duan, Huanli, Yan Li, Peizhen Hu, et al.. (2019). Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next‐generation sequencing. Histopathology. 75(6). 890–899. 67 indexed citations
18.
19.
Chen, Kuan‐Jung, Analyn Lizaso, & Ying‐Hue Lee. (2014). SIM2 maintains innate host defense of the small intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(11). G1044–G1056. 4 indexed citations
20.
Lizaso, Analyn, Kien Thiam Tan, & Ying‐Hue Lee. (2013). β-adrenergic receptor-stimulated lipolysis requires the RAB7-mediated autolysosomal lipid degradation. Autophagy. 9(8). 1228–1243. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Zulato Breakdown of academic impact, for papers by Addie Dvir Breakdown of academic impact, for papers by Spencer R. Rosario Breakdown of academic impact, for papers by Russell Broaddus Breakdown of academic impact, for papers by Clay E.S. Comstock Breakdown of academic impact, for papers by Sarab Lizard‐Nacol Breakdown of academic impact, for papers by Takamitsu Onitsuka Breakdown of academic impact, for papers by Helen Musgrove Breakdown of academic impact, for papers by A-P Meert Breakdown of academic impact, for papers by Tomohiro Sakuma
Rankless by CCL
2026